Back to top

Opus Genetics initiated with a Buy at TD Cowen

TD Cowen initiated coverage of Opus Genetics (IRD) with a Buy rating without a price target The company’s adeno-associated virus gene therapies rep...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Opus Genetics, Inc. (IRD)